Miami, FL June 15, 2014 — Modern Veterinary Therapeutics, LLC announces that the Veterinary Drugs Directorate (VDD) has approved HYMATILTM (tilmicosin injection – 300 mg/mL) in Canada. HYMATILTM, presented in a 100mL multidose vial, is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia (Pasteurella) haemolytica and Pasteurella multocida and for the reduction of morbidity associated
with bovine respiratory disease (BRD) in feedlot calves, caused by Mannheimia (Pasteurella) haemolytica and Pasteurella multocida, during the first 30 days in the
feedlot, when administered at the time of arrival. HYMATILTMis indicated for the treatment of pneumonic pasteurellosis in lambs associated with Mannheimia (Pasteurella) haemolytica. “Modern Veterinary Therapeutics, LLC is pleased to announce this new approval in Canada demonstrating our commitment to further expanding our bovine product line including entrance into the beef cattle industry as well,” said Dr. Cuong Tu Ba, President of Modern Veterinary Therapeutics, LLC.
